Article-Journal

Myelosuppression in patients treated with 177Lutetium-lilotomab satetraxetan can be predicted with absorbed dose to the red marrow as the only variable
The aim of this study was to investigate dosimetry data and clinical variables to predict hematological toxicity in non-Hodgkin …
Nov 1, 2021
Cite DOI
A Pilot Study of a Parent Emotion Socialization Intervention: Impact on Parent Behavior, Child Self-Regulation, and Adjustment
Adequate emotion regulation in children is crucial for healthy development and is influenced by parent emotion socialization. The …
Oct 15, 2021
Cite DOI
Localization of primary prostate cancer: FACBC PET/CT compared with multiparametric MRI using histopathology as reference standard
FACBC (anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid) is a FDA-approved PET-tracer in patients with suspected recurrent …
Oct 15, 2021
Cite
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
To evaluate the activity and safety of the PD-1 antibody pembrolizumab in adult patients with advanced osteosarcoma. The study was a …
Sep 1, 2021
Cite DOI
Robotic salvage pelvic lymph node dissection for locoregional recurrence after radical prostatectomy: a single institution experience
To assess treatment response (PSA < 0.2 ng/ml), need for additional therapy and complication rate after robot assisted salvage …
Aug 1, 2021
Cite DOI
Left ventricular regional glucose metabolism in combination with septal scar extent identifies CRT responders
Cardiac resynchronization therapy (CRT) is effective in selective heart failure (HF) patients, but non-response rate remains high. …
Jul 1, 2021
Cite DOI
FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of 177Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma
177Lu-lilotomab satetraxetan targets the CD37 antigen and has been investigated in a first-in-human phase 1/2a study for relapsed …
Jun 1, 2021
Cite DOI
18F-Fluciclovine PET for Assessment of Prostate Cancer with Histopathology as Reference Standard: A Systematic Review
The PET tracer 18F-fluciclovine (Axumin) was recently approved in the United States and Europe for men with suspected prostate cancer …
Apr 1, 2021
Cite DOI
Assessment of Waldeyer's ring in pediatric and adolescent Hodgkin lymphoma patients-Importance of multimodality imaging: Results from the EuroNet-PHL-C1 trial
In the EuroNet Pediatric Hodgkin Lymphoma (EuroNet-PHL) trials, decision on Waldeyer’s ring (WR) involvement is usually based on …
Apr 1, 2021
Cite DOI
Prostate-Specific Membrane Antigen PET for Assessment of Primary and Recurrent Prostate Cancer with Histopathology as Reference Standard: A Systematic Review and Meta-Analysis
Prostate-specific membrane antigen PET is a promising diagnostic tool in prostate cancer. The gold standard for the detection of …
Apr 1, 2021
Cite DOI